R. L. Parker

发表

Human tumor clonogenic assay studies of cervical cancer

C. Welander, R. L. Parker, 1987 .

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Michael Dallas, N. Sardesai, D. Weiner, 2015, The Lancet.

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

N. Sardesai, J. Kim, D. Weiner, 2012, Science Translational Medicine.

Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis

J. Hassell, A. Hartstone‐Rose, Daping Fan, 2019, AntiCancer Research.

Macrophage‐tumor cell associations: a factor in metastasis of breast cancer?

M. Brigden, B. Ashmead, I. Thornton, 1993, Journal of leukocyte biology.

Use of the Human Tumor Stem Cell Assay to Study Chemotherapy Sensitivity in Cancer of the Cervix

H. Homesley, E. Kawamoto, C. Welander, 1984, Obstetrics and gynecology.

DNA sequencing versus standard prenatal aneuploidy screening.

R. Rava, K. Jones, D. Bianchi, 2014, The New England journal of medicine.

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

N. Sardesai, J. Kim, D. Weiner, 2012, Science Translational Medicine.